Drug Delivery Business

Boston Scientific to expand its Maple Grove, Minn. campus

By

Boston Scientific Maple Grove
A rendering of Boston Scientific’s new building planned in Maple Grove, Minn., from the local planning commission agenda. Hammel, Green and Abrahamson is the architect.

Boston Scientific (NYSE:BSX) is planning a fourth building at its Maple, Grove, Minn. campus to support expanded nitinol stent manufacturing.

The Maple Grove Planning Commission is scheduled to review project plans tonight for the roughly 76,000 ft2 building.

“This new building will allow for movement of some production currently taking place in existing buildings on that campus, and support increased needs for growing product lines such as the  Watchman left atrial appendage closure device, Eluvia drug-eluting vascular stent system and Innova stent system,” Boston Sci said in a statement that spokesperson Kate Haranis shared with DDBN‘s sister site MassDevice.

Get the full story on MassDevice. 

IN CASE YOU MISSED IT

About Chris Newmarker

Chris Newmarker is the executive editor of WTWH Media life science's news websites and publications including MassDevice, Medical Design & Outsourcing and more. A professional journalist of 18 years, he is a veteran of UBM (now Informa) and The Associated Press whose career has taken him from Ohio to Virginia, New Jersey and, most recently, Minnesota. He’s covered a wide variety of subjects, but his focus over the past decade has been business and technology. He holds bachelor’s degrees in journalism and political science from Ohio State University. Connect with him on LinkedIn or email at cnewmarker@wtwhmedia.com.